Pharma’s Almanac featured Model Medicines among five emerging biotechs to watch, spotlighting the company’s use of GALILEO™ to accelerate drug discovery and identify new therapeutic opportunities. The feature placed Model Medicines alongside a select group of small biotechs advancing differentiated approaches across drug development, with particular attention to companies using new technologies to address long-standing challenges in pharma innovation.